Immunic, Inc. (IMUX)
NASDAQ: IMUX · IEX Real-Time Price · USD
1.250
+0.010 (0.81%)
Apr 24, 2024, 11:25 AM EDT - Market open
Immunic Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Immunic stock have an average target of 8.50, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 580.00% from the current stock price of 1.25.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunic stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +700.00% | Apr 5, 2024 |
| Wedbush | Wedbush | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +460.00% | Oct 10, 2023 |
| Wedbush | Wedbush | Buy Reiterates $5 | Buy | Reiterates | $5 | +300.00% | Jul 27, 2023 |
| Wedbush | Wedbush | Buy Initiates $5 | Buy | Initiates | $5 | +300.00% | Jan 31, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $9 → $5 | Buy → Hold | Downgrades | $9 → $5 | +300.00% | Oct 21, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.01
from -2.11
EPS Next Year
-0.94
from -1.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 734.9M | 1.1B | 1.5B |
| Avg | n/a | n/a | 178.5M | 367.2M | 523.7M |
| Low | n/a | n/a | n/a | n/a | 67.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 518.0% | 298.6% |
| Avg | - | - | - | 105.8% | 42.6% |
| Low | - | - | - | - | -81.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.99 | -0.75 | 5.46 | 12.64 | 16.03 |
| Avg | -1.01 | -0.94 | 1.11 | 5.34 | 7.11 |
| Low | -1.04 | -1.13 | -0.97 | -1.53 | -1.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,036.7% | 200.0% |
| Avg | - | - | - | 380.6% | 33.0% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.